659 related articles for article (PubMed ID: 7105051)
1. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
2. Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group.
Moertel CG; Lavin PT
Cancer Treat Rep; 1979; 63(11-12):1863-9. PubMed ID: 393381
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
Safran H; Akerman P; Cioffi W; Gaissert H; Joseph P; King T; Hesketh PJ; Wanebo H
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):53-7. PubMed ID: 10210540
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of stomach cancer].
Gropp C; Havemann K
Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
[TBL] [Abstract][Full Text] [Related]
5. Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach.
Cazap EL; Gisselbrecht C; Smith FP; Estevez RA; Alvarez CA; Lagarde C; Hannois A; Ahmed S; Schein PS; Woolley PV
Cancer Treat Rep; 1986 Jun; 70(6):781-3. PubMed ID: 3524826
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagus.
Kulke MH; Wu B; Clark JW; Enzinger PC; Lynch TJ; Vincitore M; Michelini A; Fuchs CS
Cancer Invest; 2006; 24(3):229-34. PubMed ID: 16809148
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
9. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM
Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837
[No Abstract] [Full Text] [Related]
10. 5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer.
Bunn PA; Nugent JL; Ihde DC; Cohen MH; Eddy JL; Minna JD
Cancer Treat Rep; 1978 Sep; 62(9):1287-93. PubMed ID: 356983
[TBL] [Abstract][Full Text] [Related]
11. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK
Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742
[TBL] [Abstract][Full Text] [Related]
12. [ACNU and methyl-CCNU in combination chemotherapy for advanced gastric cancer: a randomized comparative study. Shanghai ACNU Collaborative Study Group].
Xiao S; Li D; Zhang D
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):30-3. PubMed ID: 8732108
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma.
Gibson MK; Holcroft CA; Kvols LK; Haller D
Oncologist; 2005 Feb; 10(2):132-7. PubMed ID: 15709215
[TBL] [Abstract][Full Text] [Related]
14. Phase II-III chemotherapy studies in advanced gastric cancer. The Gastrointestinal Tumor Study Group.
Cancer Treat Rep; 1979; 63(11-12):1871-6. PubMed ID: 393382
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of advanced gastric carcinoma (stage IV): a randomized study of FAM versus 5-FU plus BCNU.
Villar A; Asensio F; Candel M; Delgado F; Garcia J; Lledó S; Redón J; Roig JV; Sanchez A; Sanchis C
Chemioterapia; 1987 Feb; 6(1):57-62. PubMed ID: 3103932
[TBL] [Abstract][Full Text] [Related]
16. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).
Bitran JD; Desser RK; Kozloff MF; Billings AA; Shapiro CM
Cancer Treat Rep; 1979; 63(11-12):2049-51. PubMed ID: 393388
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer.
Cocconi G; DeLisi V; Di Blasio B
Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment.
Hagin GD; Jain A
Am J Gastroenterol; 1985 Nov; 80(11):835-7. PubMed ID: 3840327
[TBL] [Abstract][Full Text] [Related]
19. [Biochemical modulation of 5-FU--effect of low dose CDDP].
Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of 5-FU alone or combined with carmustine, doxorubicin, and mitomycin (BAFMi) in the treatment of advanced gastric cancer: a phase III trial of the Italian Clinical Research Oncology Group (GOIRC).
De Lisi V; Cocconi G; Tonato M; Di Costanzo F; Leonardi F; Soldani M
Cancer Treat Rep; 1986 Apr; 70(4):481-5. PubMed ID: 3516397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
